52
Views
10
CrossRef citations to date
0
Altmetric
Original Research

Elevated serum levels of vascular endothelial growth factor predict a poor prognosis of platinum-based chemotherapy in non-small cell lung cancer

, , , , , , , , & show all
Pages 409-415 | Published online: 18 Jan 2017

References

  • ParkinDMBrayFFerlayJPisaniPGlobal cancer statistics, 2002CA Cancer J Clin20055527410815761078
  • AzzoliCGBakerSJrTeminSAmerican Society of Clinical Oncology Clinical Practice Guideline update on chemotherapy for stage IV non-small-cell lung cancerJ Clin Oncol200927366251626619917871
  • SandlerAGrayRPerryMCPaclitaxel-carboplatin alone or with bevacizumab for non-small-cell lung cancerN Engl J Med2006355242542255017167137
  • FerraraNRole of vascular endothelial growth factor in the regulation of angiogenesisKidney Int199956379481410469350
  • ThurstonGKitajewskiJVEGF and Delta-Notch: interacting signalling pathways in tumour angiogenesisBr J Cancer20089981204120918827808
  • KondoSAsanoMMatsuoKOhmoriISuzukiHVascular endothelial growth factor/vascular permeability factor is detectable in the sera of tumor-bearing mice and cancer patientsBiochim Biophys Acta1994122122112148148401
  • TasFDuranyildizDOguzHCamlicaHYasaseverVTopuzESerum vascular endothelial growth factor (VEGF) and bcl-2 levels in advanced stage non-small cell lung cancerCancer Invest200624657658016982461
  • YazarASoydincHErtanEYasaseverVTasFThe role of serum vascular endothelial growth factor and matrix metalloproteinase-9 in predicting response to chemotherapy in patients with advanced nonsmall cell lung cancerSouth Med J20081013327328
  • LissoniPRovelliFMaluganiFBrivioFFumagalliLGardaniGSChanges in circulating VEGF levels in relation to clinical response during chemotherapy for metastatic cancerInt J Biol Markers200318215215512841685
  • HsuHYJoosTOKogaHMultiplex microsphere-based flow cytometric platforms for protein analysis and their application in clinical proteomics – from assays to resultsElectrophoresis200930234008401919960465
  • ZhangYWuJZZhangJYDetection of circulating vascular endothelial growth factor and matrix metalloproteinase-9 in non-small cell lung cancer using Luminex multiplex technologyOncol Lett20147249950624396477
  • FuBHFuZZMengWGuTSunXDZhangZPlatelet VEGF and serum TGF-beta1 levels predict chemotherapy response in non-small cell lung cancer patientsTumour Biol20153686477648325820820
  • BambaceNMLevisJEHolmesCEThe effect of P2Y-mediated platelet activation on the release of VEGF and endostatin from plateletsPlatelets2010212859320063989
  • FoekensJAPetersHAGrebenchtchikovNHigh tumor levels of vascular endothelial growth factor predict poor response to systemic therapy in advanced breast cancerCancer Res200161145407541411454684
  • HanHSilvermanJFSantucciTSVascular endothelial growth factor expression in stage I non-small cell lung cancer correlates with neoangiogenesis and a poor prognosisAnn Surg Oncol200181727911206229
  • YanoTTanikawaSFujieTMasutaniMHorieTVascular endothelial growth factor expression and neovascularisation in non-small cell lung cancerEur J Cancer200036560160910738124
  • OffersenBVPfeifferPHamilton-DutoitSOvergaardJPatterns of angiogenesis in nonsmall-cell lung carcinomaCancer20019181500150911301398
  • FontaniniGVignatiSLucchiMNeoangiogenesis and p53 protein in lung cancer: their prognostic role and their relation with vascular endothelial growth factor (VEGF) expressionBr J Cancer1997759129513019155049
  • BremnesRMCampsCSireraRAngiogenesis in non-small cell lung cancer: the prognostic impact of neoangiogenesis and the cytokines VEGF and bFGF in tumours and bloodLung Cancer200651214315816360975
  • RoskoskiRJrVascular endothelial growth factor (VEGF) signaling in tumor progressionCrit Rev Oncol Hematol200762317921317324579
  • GrunewaldMAvrahamIDorYVEGF-induced adult neovascularization: recruitment, retention, and role of accessory cellsCell2006124117518916413490
  • BrattstromDBergqvistMHesseliusPElevated preoperative serum levels of angiogenic cytokines correlate to larger primary tumours and poorer survival in non-small cell lung cancer patientsLung Cancer2002371576312057868
  • ChoiJHKimHCLimHYVascular endothelial growth factor in the serum of patients with non-small cell lung cancer: correlation with platelet and leukocyte countsLung Cancer2001332–317117911551412
  • SalgadoRVermeulenPBBenoyIPlatelet number and interleukin-6 correlate with VEGF but not with bFGF serum levels of advanced cancer patientsBr J Cancer1999805–689289710360671
  • LudoviniVGregorcVPistolaLVascular endothelial growth factor, p53, Rb, Bcl-2 expression and response to chemotherapy in advanced non-small cell lung cancerLung Cancer2004461778515364135
  • KumarSGuleriaRSinghVBhartiACMohanADasBCEfficacy of plasma vascular endothelial growth factor in monitoring first-line chemotherapy in patients with advanced non-small cell lung cancerBMC Cancer2009942119958548
  • ArjaansMSchroderCPOostingSFDafniUKleibeukerJEde VriesEGVEGF pathway targeting agents, vessel normalization and tumor drug uptake: from bench to bedsideOncotarget2016716212472125826789111
  • DelmottePMartinBPaesmansMVEGF and survival of patients with lung cancer: a systematic literature review and meta-analysisRev Mal Respir2002195 Pt 1577584 French12473944
  • DudekAZMahasethHCirculating angiogenic cytokines in patients with advanced non-small cell lung cancer: correlation with treatment response and survivalCancer Invest200523319320015945504
  • Jantus-LewintreESanmartinESireraRCombined VEGF-A and VEGFR-2 concentrations in plasma: diagnostic and prognostic implications in patients with advanced NSCLCLung Cancer201174232633121481963
  • ChakraMPujolJLLamyPJCirculating serum vascular endothelial growth factor is not a prognostic factor of non-small cell lung cancerJ Thorac Oncol20083101119112618827607
  • BrattströmDBergqvistMHesseliusPLarssonAWageniusGBrodinOSerum VEGF and bFGF adds prognostic information in patients with normal platelet counts when sampled before, during and after treatment for locally advanced non-small cell lung cancerLung Cancer2004431556214698537
  • TherassePArbuckSGEisenhauerEANew guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of CanadaJ Natl Cancer Inst200092320521610655437